NCT07723963: A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 260 planned
- Started
- 18 Sep 2026
- Primary completion
- 1 Aug 2028
- Arms
- JZP926 Capsule, Open-Label Extension: JZP926 Capsule
- Results
- None posted
- 23 Jul 2026: Trial registered
- 18 Sep 2026: Trial started